Published: Just now
Two pharmaceutical companies in Indonesia lose their licenses to manufacture liquid medicine after 159 children died from acute kidney damage.
The companies PT Yarindo Farmatama and PT Universal Pharmaceutical Industries changed suppliers of an ingredient for the medicines in question, and the new ingredient was found to be contaminated with other types of chemicals. It is believed to be the cause of a rise in the number of cases of acute kidney problems in children since the end of August.
The decision to withdraw the licenses comes from the authority BPOM, which is responsible for controlling, among other things, food and pharmaceuticals in Indonesia.
The authority also intends to take the companies to court in connection with the deaths.